Biodesix, Inc. Common Stock BDSX

$8.53 -57.01% at last close

Analyst Consensus

Consensus Rating
Buy (6 Buy · 0 Hold · 0 Sell)
Average Price Target
$35.00
Implied Upside
+310.3%
Price Target Range
$30.00 – $40.00
Analysts (12 mo)
6

Recent Analyst Actions

DateFirmActionRatingPrice Target
2026-11-06
Lake StreetThomas Flaten
Maintains Buy $40 → $30
2026-10-13
TD CowenDan Brennan
Maintains Buy $30 → $40
2026-09-25
HC Wainwright & Co.Yi Chen
Maintains Buy $27 → $38
2026-08-10
Canaccord GenuityKyle Mikson
Maintains Buy $27 → $35
2026-08-06
HC Wainwright & Co.Yi Chen
Maintains Buy $26 → $27
2026-06-25
Roth CapitalMax Masucci
Initiates coverage on Buy $32
2026-06-18
Canaccord GenuityKyle Mikson
Maintains Buy $22 → $27
2026-06-15
HC Wainwright & Co.Yi Chen
Initiates coverage on Buy $26
2026-05-05
Canaccord GenuityKyle Mikson
Maintains Buy $20 → $22
2026-02-27
William BlairBrian Weinstein
Upgrades Market perform → Outperform —
2026-02-17
Canaccord GenuityKyle Mikson
Maintains Buy $20
2025-09-19
Canaccord GenuityKyle Mikson
Maintains Buy $30 → $20
2025-05-21
ScotiabankSung Ji Nam
Maintains Sector outperform $3 → $2
2025-05-14
Craig-HallumBill Bonello
Maintains Buy $3 → $2
2025-05-14
Lake StreetThomas Flaten
Maintains Buy $3 → $2
2025-05-14
Canaccord GenuityKyle Mikson
Maintains Buy $3 → $2
2025-05-14
William BlairBrian Weinstein
Downgrades Outperform → Market perform —
2025-04-29
Canaccord GenuityKyle Mikson
Maintains Buy $4 → $3
2024-09-16
ScotiabankSung Ji Nam
Initiates coverage on Sector outperform $3
2024-07-26
Craig-HallumBill Bonello
Initiates coverage on Buy $3
2024-05-13
TD CowenDan Brennan
Initiates coverage on Buy $3
2024-05-03
Lake Street
Initiates coverage on Buy $3
2024-03-04
Canaccord GenuityKyle Mikson
Reiterates Buy $4
2023-12-07
Canaccord GenuityKyle Mikson
Reiterates Buy $4
2022-05-12
Morgan StanleyTejas Savant
Maintains Equal-weight $7 → $5
2022-04-20
Cowen & Co.Max Masucci
Initiates coverage on Outperform —
2021-11-17
Morgan StanleyTejas Savant
Downgrades Overweight → Equal-weight $21 → $11
2021-05-12
Morgan StanleyTejas Savant
Maintains Overweight $25 → $23
2021-03-18
Morgan StanleyTejas Savant
Maintains Overweight $20 → $25
2021-02-02
Canaccord GenuityMax Masucci
Maintains Buy $27 → $31

Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.

Key Stats

Last Close
$8.53
Market Cap
$209.33 million
52-Week Range
$5.26 – $31.97
Average Volume
150K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.